Cas 207281-33-2,4-(4-acetoxyphenyl)-3-(4-fluorophenyl)-7-methoxy-coumarin

207281-33-2

Post Buying Request

Basic information

Product Name: 4-(4-acetoxyphenyl)-3-(4-fluorophenyl)-7-methoxy-coumarin
Synonyms: 4-(4-acetoxyphenyl)-3-(4-fluorophenyl)-7-methoxy-coumarin
CAS NO:207281-33-2
Molecular Formula:
Molecular Weight: 404.394
EINECS: N/A
Product Categories: N/A

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-(4-acetoxyphenyl)-3-(4-fluorophenyl)-7-methoxy-coumarin(CAS DataBase Reference)
NIST Chemistry Reference: 4-(4-acetoxyphenyl)-3-(4-fluorophenyl)-7-methoxy-coumarin(207281-33-2)
EPA Substance Registry System: 4-(4-acetoxyphenyl)-3-(4-fluorophenyl)-7-methoxy-coumarin(207281-33-2)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 207281-33-2(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

207281-33-2 Suppliers

Recommended suppliers

207281-33-2 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 207281-33-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,0,7,2,8 and 1 respectively; the second part has 2 digits, 3 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 207281-33:
(8*2)+(7*0)+(6*7)+(5*2)+(4*8)+(3*1)+(2*3)+(1*3)=112
112 % 10 = 2
So 207281-33-2 is a valid CAS Registry Number.

207281-33-2Upstream product

207281-33-2Downstream Products

207281-29-6 3-(4-fluorophenyl)-4-(4-hydroxyphenyl)-7-methoxy-2H-chromene

207281-33-2Relevant academic research and scientific papers

Synthesis and pharmacological evaluation of novel cis-3,4-Diaryl-hydroxychromanes as high affinity partial agonists for the estrogen receptor

Bury, Paul S.,Christiansen, Lise B.,Jacobsen, Poul,Jorgensen, Anker S.,Kanstrup, Anders,Narum, Lars,Bain, Steven,Fledelius, Christian,Gissel, Birgitte,Hansen, Birgit S.,Korsgaard, Niels,Thorpe, Susan M.,Wassermann, Karsten

, p. 125 - 145 (2007/10/03)

The syntheses and in vitro pharmacological evaluation of a number of cis-3,4-diaryl-hydroxy-chromanes are reported, along with the results of a thorough in vivo profiling of the tissue-selective estrogen partial-agonist NNC 45-0781 [3, (-)-(3S,4R)-7-hydro

NOVEL CIS-3,4-CHROMAN DERIVATIVES USEFUL IN THE PREVENTION OR TREATMENT OF ESTROGEN RELATED DISEASES OR SYNDROMES

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula I a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen related di

cis3, 4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

-

, (2008/06/13)

cis-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

-

, (2008/06/13)

Trans-3,4-chroman derivatives useful in the prevention or treatment of estrogen related diseases or syndromes

-

, (2008/06/13)

The present invention relates to therapeutically active compounds of formula I STR1 a method of preparing the same and to pharmaceutical compositions comprising the compounds. The novel compounds are useful in the prevention or treatment of estrogen relat

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 207281-33-2